Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05607381 · ClinicalTrials.gov registry record · NA
Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
A NA study of Low Back Pain and Opioid Use, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT05607381: Recruiting NA study of Low Back Pain and Opioid Use, sponsored by University of Utah.
NCT05607381 is a NA study of Low Back Pain and Opioid Use that is actively recruiting participants, run by University of Utah. The registered enrollment target is 150 participants, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05607381, a NA study of Low Back Pain and Opioid Use, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to see how a mindfulness meditation-based intervention affects pain. Specifically, we are interested in understanding the pain-relieving brain mechanisms of mindfulness meditation-based therapy for patients with opioid-treated chronic low back pain.
Primary Outcome
Changes in blood oxygenation levels to thermally noxious stimuli (48°C) will be assessed.
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Meditation
Study Locations (2)
California
- University of California, San Diego - La Jolla
Utah
- Center on Mindfulness and Integrative Health Intervention Development - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT05607381 shows while recruiting
NCT05607381 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 503-participant average among 122 other Low Back Pain trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT05607381 reports a single indexed study location in California, Utah.
Frequently Asked Questions
What is clinical trial NCT05607381 about?
NCT05607381 is a clinical study titled "Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain". The purpose of this research study is to see how a mindfulness meditation-based intervention affects pain. Specifically, we are interested in understanding the pain-relieving brain mechanisms of mindfulness meditation-based therapy for patients with opioid-treated chronic low back pain.
What is the current status of trial NCT05607381?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-11-30. Estimated completion is 2027-06-30.
What conditions does trial NCT05607381 study?
This clinical trial studies the following conditions: Low Back Pain, Opioid Use.
What interventions are being tested in trial NCT05607381?
The interventions under investigation include: Usual care (OTHER), Meditation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05607381?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05607381 being conducted?
This trial has 2 study locations across California, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05607381's enrollment target sits among peer trials
150 43rd of 122 higher than 79 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
-
Ischemic Preconditioning in Osteoarthritis and Back Pain
RECRUITING · NA
-
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
RECRUITING · NA
-
Perspectives on Spinal Manipulative Therapy for Low Back Pain
RECRUITING · NA
-
Effect of Lumbar Manipulation on Intervertebral Motion, Pain, and Disability
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI